Company / Return on Equity (ROE)
BIOMERICA INC Return on Equity (ROE) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-75.4%
FY2024
5-year range
-85.8% / -49.1%
FY2020-FY2024
Trend
-48.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
BIOMERICA INC reports negative total equity of -75.4% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-75.4% in FY2024 with a 5-year CAGR of -15.3%.
Improved from -85.8% to -75.4% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -26.3pp
- 5-Year Change
- -15.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 48.0% year-over-year.
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -75.4% | -48.0% |
| FY2023 | -51.0% | +40.6% |
| FY2022 | -85.8% | -74.7% |
| FY2021 | -49.1% | +6.3% |
| FY2020 | -52.4% | +12.8% |
| FY2019 | -60.1% | -8.7% |
| FY2018 | -55.3% | -69.4% |
| FY2017 | -32.6% | -87.6% |
| FY2016 | -17.4% | +35.0% |
As of FY2024 · SEC Form 10-K · Last checked Jun 22, 2026